Combatting cancer: how innovation actors are changing the landscape

Combatting cancer: how innovation actors are changing the landscape

Discover the role of patents on cancer innovation and join us for the launch of a new study and EPO tools supporting scientists, health tech startups, and the cancer research community.

Language: English

Speakers and panellists: to be confirmed

More information: In a world increasingly propelled by technological advancements and governments' commitment to combatting cancer, often backed by multi-billion-euro public funding programs, it is essential to understand how the landscape of oncology research is evolving. Is the traditional innovation ecosystem undergoing a shift? What is the influence of universities, public research organisations, and startups alongside large corporations in the development of cancer-fighting innovations?

Based on a thorough analysis of technological trends spanning a 50-year period from our extensive patent databases, the EPO will present the key players in cancer-fighting innovation, highlighting leading countries in fields such as immunotherapy, biopsies, and bioinformatics, which are poised to redefine cancer diagnosis and treatment, among other noteworthy findings.

Furthermore, to facilitate the identification of cutting-edge cancer-fighting technologies in global patent databases, a new Espacenet tool developed specifically for the scientific community, in close collaboration with several European national patent offices, will be introduced. Additionally, considering patents as a crucial asset for economic actors seeking investments, especially in the health sector, our Deep Tech Finder, updated with new filters, will enable the search for startups specialised in cancer-fighting technology in Europe.

As we navigate the complexities of this rapidly evolving field, three experts will share their insights in this online event on international technology trends, new business models, and policymaking.

We invite you to join us in exploring these multifaceted elements of innovation that support the pursuit of breakthroughs in the fight against cancer.

Who should attend: This online event is targeted towards the cancer research ecosystem, which can benefit from new tools, analyses, and debates on the future of innovation in oncology. This includes cancer research organisations in Europe and beyond, policymakers at national and EU level, industry involved in health/cancer innovation health tech startups, universities, public research organisations, National Patent Offices, and other industry stakeholders, such as cancer patient associations and intellectual property specialists in the health sector.

Registration Form: Registration Form (epo.org)